Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

U.S. to donate 500 million Pfizer vaccine doses to the world -sources

U.S. to donate 500 million Pfizer vaccine doses to the world -sources

By Trevor Hunnicutt and Carl O’Donnell

WASHINGTON (Reuters) – The Biden administration plans to donate 500 million Pfizer coronavirus vaccine doses to nearly 100 countries over the next two years, three sources familiar with the matter told Reuters on Wednesday.

The United States is likely to distribute 200 million shots this year and another 300 million in the first half of next year to 92 lower-income countries and the African Union, they said.

The donations will go through the COVAX vaccine program that distributes COVID-19 shots to low- and middle-income countries. The program is led by the World Health Organization and the Global Alliance for Vaccines and Immunization (GAVI).

GAVI did not respond to a request for comment.

U.S. President Joe Biden will announce the deal on Thursday at the Group of Seven meeting of the world’s wealthiest countries in Britain, one of the people said.

The deal was negotiated over the past four weeks by White House COVID-19 response coordinator Jeff Zients and the coronavirus task force team, one of the sources said.

CNBC reported on Wednesday that the United States is also talking with Moderna Inc about buying some of its shots to donate to other countries.

A Moderna spokesperson said the company is interested in possibly providing the U.S. government with COVID-19 shots to give to low- and middle-income countries but declined to comment on any discussions.

The White House and Pfizer declined to comment.

The U.S. president told reporters before boarding Air Force One for Britain that he had a global vaccine strategy and would be announcing it but did not offer details.

The White House has been under mounting pressure to boost donations of COVID-19 shots to other countries.

The United States has given at least one shot to around 64% of its adult population and has begun vaccinating adolescents, while other countries like Brazil and India are struggling to get desperately needed doses.

“This action sends an incredibly powerful message about America’s commitment to helping the world fight this pandemic,” said Tom Hart, acting chief executive of The ONE Campaign, a nonprofit working to end extreme poverty and preventable disease by 2030.

The administration is also using the U.S. vaccine supply as a tool to counter Chinese and Russian vaccine diplomacy.

The Biden administration had said it would share 80 million vaccine doses worldwide by the end of June. The White House earlier this year also pledged $4 billion to COVAX and urged other countries to boost donations as well.

Pfizer has said it expects to produce as many as 3 billion COVID-19 shots in 2021 and upwards of 4 billion next year.

The New York Times reported that the United States will buy the doses at a “not-for-profit” price, citing people familiar with the deal. They also reported that Pfizer CEO Albert Bourla will accompany Biden during the announcement.

The agreement is in addition to the 300 million shots the United States has already purchased from Pfizer and brings the total number of Pfizer/BioNTech shots purchased by the United States to 800 million, the Times said.

(Additional reporting by Doina Chiacu, Michael Erman and Allison Martell; Editing by Howard Goller and Bill Berkrot)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post